VitaHealth Analysis Comprehensive Cancer – Male
What’s it used for?
The Men’s Comprehensive Cancer Panel provides indicators for the common cancers that affect males. These include cancers of the prostate, testes, large intestine (colon and rectal), stomach, pancreas, liver, and breast.
The primary purpose of the PSA test is to screen for prostate cancer. High levels may indicate an inflamed or enlarged prostate or the existence of prostate cancer. The presence of the carcinoembryonic antigen (CEA) in the blood may indicate certain kinds of cancers, typically colon and rectal, but sometimes pancreas, breast or lung. Similarly, the presence of alpha-fetoprotein (AFP) in men may point toward cancer of the stomach, testicles, pancreas or liver. High levels may indicate Hodgkins disease, brain tumors, renal cell cancer or lymphoma. CA 27-29, CA15-3 and CA 19-9 are tumor markers for breast cancer and pancreatic cancer respectively.